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ABSTRACT 
Thyroid disorder is very common in Pakistani population and most of the patients either sex having thyroid problems which may disturb various body systems 
for example variation in systolic / diastolic blood pressure, pulse rate, serum creatinine level and ALT / SGPT (Alanine Aminotransferase) and AST / SGOT 
(Aspartate Aminotransferase) levels. The purpose of our study is to determine the effects of thyroid dysfunction on blood pressure, pulse rate, renal and liver 
functions and there correlation with thyroid status before and after treatment in patients with hypo and hyperthyroidism respectively. The results showed that 
there are significant differences in the levels of biochemical parameters (Serum Creatinine, ALT, AST, FT3, FT4 and TSH) as compared to normal in both 
groups. Significant changes were also found in blood pressure and pulse rate of both male and female groups. 
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INTRODUCTION 
The thyroid hormones  play important role in human  body. 
Therefore, different research studies carried out on this aspect 
world wide
1. 
Thyroid disorders are amongst the most prevalent of medical 
conditions. Their manifestations vary considerably from area 
to area and are determined principally by the availability of 
iodine  in  the  diet.  Epidemiological  studies  of  thyroid 
dysfunction  have  limitations,  for  example  the  definition  of 
overt  hypothyroidism  and  subclinical  hypothyroidism,  the 
selection  criteria  of  the  sample  used,  the  influence  of  age, 
sex,  genetic  and  environmental  factors  and  the  different 
techniques  used  for  the  measurement  of  thyroid  hormones 
and  the  relative  rareness  of  incidence  data
2.  Data  on  the 
involvement  of  liver  enzymes  and  serum  creatinine  with 
thyroid  abnormalities  are  also  limited.  In  our  study  it  has 
been calculated from newly diagnosed untreated patient from 
short follow-up studies (3 months). 
 
MATERIAL AND METHODS 
Collection of the Sample 
About  110  blood  samples  from  patients  suffering  with 
Patients with newly diagnosed primary hypothyroidism who 
had  been  referred  to  the  Division  of  Endocrinology  and 
cardiovascular at KIRAN hospital Karachi, Pakistan between 
January 2011 and February 2013 were included in this study. 
A  consent  form  was  obtained  from  all  patients.  42  blood 
samples were collected from healthy individuals at different 
age group. The excluded criteria in this study were patients 
with  thyroid  cancer,  neoplastic  disease  and  secondary 
hypothyroidism. 
 
Reagents and Chemicals 
The  necessary  kits  and  chemicals  were  obtained  from 
international  companies.  Ready-made  reagents  were 
purchased  from  Merck  and  Scharlau  for  Biochemical 
parameters such as ALT, AST and Serum creatinine and were 
estimated  as  per  standard  procedure.  Thyroid  hormonal 
imbalances  like  Thyrotropin  (TSH),  Triiodothyronine  (T3), 
Thyroxine (T4) in serum were detected using RIA test. Serum 
creatinine,  SGOT  /  AST,  SGPT  /  ALT  were  assayed  by 
following  the  recommended  Laboratory  protocol.  Physical 
parameters  such  as  pulse  rate,  systolic  and  diastolic  blood 
pressure were also measured.  
 
Statistical Analysis 
Statistical analysis was performed by using ‘Z’ test at 0.05 % 
level of significance. The results were calculated as mean ± 
SEM. 
 
RESULTS 
The results of  male and  female  groups  of hyperthyroidism 
and hypothyroidism were presented in Table 1, 2 and Graph 
1,  2.  There  was  significant  difference  in  the  levels  of 
biochemical parameters (Serum Creatinine, ALT, AST, FT3, 
FT4,  and  TSH  as  compared  to  normal  in  both  groups. 
Significant changes were  also  found in blood  pressure  and 
pulse  rate  of  both  male  and  female  groups.  In  male 
hyperthyroid group (diagnosed) SGOT and serum creatinine 
were  slightly  decreased  where  as  in  male  and  female 
hypothyroid groups (diagnosed) were increased respectively. 
In  female  hyperthyroid  group  only  serum  creatinine  was 
decreased. Blood pressure and pulse rate were increased in 
both  groups  of  diagnosed  hyperthyroid  and  decreased  in 
hypothyroid  male  and  female  groups.  Mean  differences  in 
control  and diagnosed  groups  of  both hyperthyroidism  and 
hypothyroidism were comparable but there was no significant 
difference observed with respect to blood pressure and pulse 
rate in between groups (Graph 1, 2). It was also observed that 
in diagnosed male hypothyroid group serum creatinine level 
was  increased  (2.12  ±  0.06)  significantly  as  compared  to 
female group (1.72 ± 0.05).  Mansoor Ahmad et al. Int. Res. J. Pharm. 2013, 4 (8) 
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Table 1: Different Biochemical Parameters for Male in Hyper and Hypothyroidism Before and After Treatment 
 
Groups 
Reference range Units 
Biochemical Parameters 
SGPT / ALT  SGOT / AST  Serum Creatinine  FT3  FT4  TSH 
10-40 U / l  10-30 U / l  0.5-1.01 mg / dl  1.78-3.77 ng / l  0.77-1.86 ng / l  0.17-4.05 U / l 
Control (20)  27.4 ± 2.13  17.2 ± 1.37  0.68 ± 0.06  2.50 ± 0.05  1.02 ± 0.03  273 ± 0.81 
Diagnosed Hyperthyroid  13.68 ± 1.52  9.24 ± 1.87  0.44 ± 0.10  4.98 ± 0.04  2.17 ± 0.07  0.041 ± 0.45 
Treated Hyperthyroid  22.31 ± 1.21  15.6 ± 1.27  0.52 ± 0.06  2.23 ± 0.05  1.74 ± 0.03  1.45 ± 0.81 
Diagnosed Hypothyroid  47.6 ± 2.21  34.7 ± 1.87  2.12 ± 0.06  0.80 ± 0.04  0.47 ± 0.03  77.95 ± 0.81 
Treated Hypothyroid  39.6 ± 1.83  27.2 ± 1.87  1.0 ± 0.06  1.45 ± 0.04  0.74 ± 0.05  45.1 ± 0.72 
Results are expressed in Mean ± SEM, p < 0.05Control: N = 42 (Male 24, Female 31), Hyperthyroid 55 (Male 24, Female 31), Hypothyroid 55(Male 24, 
Female 31), Average age: 38 (23-53) 
 
Table 2: Different Biochemical Parameters for Female in Hyper and Hypothyroidism Before and After Treatment 
 
Groups 
 
Reference range Units 
Biochemical Parameters 
SGPT / ALT  SGOT / AST  Serum Creatinine  FT3  FT4  TSH 
10-40 U / l  10-30 U / l  0.5-1.01 mg / dl  1.78-3.77 ng / l  0.77-1.86 ng / l  0.17-4.05 U / l 
Control (22)  28.6 ± 1.13  18.2 ± 1575  0.78 ± 0.03  2.21 ± 0.04  1.23 ± 0.05  2.45 ± 0.61 
Diagnosed Hyperthyroid  13.8 ± 1.83  9.3 ± 1.47  0.39 ± 0.07  4.91 ± 0.03  2.18 ± 0.06  0.054 ± 0.54 
Treated Hyperthyroid  17.2 ± 2.14  13.3 ± 1.77  0.51 ± 0.04  3.65 ± 0.05  1.85 ± 0.06  1.34 ± 0.75 
Diagnosed Hypothyroid  44.3 ± 1.42  35.8 ± 1.17  1.72 ± 0.05  0.82 ± 0.15  0.54 ± 0.05  78.3 ± 0.41 
Treated Hypothyroid  32.3 ± 2.03  27.3 ± 1.27  1.02 ± 0.05  1.89 ± 0.05  0.81 ± 0.03  15.8 ± 0.61 
Results are expressed in Mean ± SEM, p < 0.05 Control: N = 42 (Male 24, Female 31), Hyperthyroid 55 (Male 24, Female 31), Hypothyroid 55(Male 24, 
Female 31), Average age: 38 (23-53) 
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Graph 1: Effect of Thyroid Dysfunction on Pulse rate, Systolic and Diastolic Blood Pressure in Male Group 
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Graph 2: Effect of Thyroid Dysfunction on Pulse rate, Systolic and Diastolic Blood Pressure in Female Group 
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DISCUSSION 
Thyroid  dysfunction  is  associated  with  changes  in  serum 
creatinine.  In  agreement  with  reported  study
1,  serum 
creatinine values in our study were higher in hypothyroidism 
and lower in hyperthyroidism as compared with the values of 
the same individual in the euthyroid state
5.  In  case  of low 
serum creatinine level there was a decreased in muscle mass 
and  results  in  muscular  weakness,  dystrophy  and  poor 
physical activity. However, elevated serum creatinine level in 
hypothyroid state results in decreased  GFR but not related 
with  altered  creatnine  kinase  levels
6.  The  present  findings 
indicated  that  increased  serum  creatinine  levels  during 
hypothyroid  disease  can  be  easily  developed  and  more 
significantly increased in male group. This may be due to the 
impaired  glycogenolysis  and  mitochondrial  oxidative 
metabolism
7. Significant changes in glomerular and tubular 
functions  and  elcetrolyte  disbalance  were  found  in  thyroid 
dysfunction. It was also observed that pulse rate and blood 
pressure  were  reduced  in  hypothyroidism.  Since 
hypothyroidism is associated with reduction in GFR therefore 
results  in  hyponatremia  and  reduction  in  blood  pressure
8. 
Similarly  low  thyroid  level  increased  the  liver  enzymes 
(Table 1, 2). Since in hypothyroidism utilization of glucose 
for  energy  is  decreased  and  body  starts  utilizing  fat  and 
proteins. Therefore, that causes an increase in liver enzymes
9-
10.  It  was  also  observed  that  after  treatment  these 
abnormalities  were  found  reversed
11-13.  But  the  problems 
associated  with  cardiac  dysfunctioning  are  directly  related 
with  the  increased  or  decreased  level  of  thyroid  hormone. 
Since  calcium  activated  ATPase  have  involvement  in 
regulation of cardiac functions which is directly affected by 
altered thyroid hormone levels.  Therefore, change in blood 
pressure and pulse rate was observed in this study
14-15. More 
over different studies have shown that kidney dysfuntioning 
in  hypothyroidism  can  increased  PVR  (peripheral  vascular 
resistant)  and  decreased  in  myocardial  contraction  and 
hyperlipidemaia
16-17. So in  most  of the hypothyroid  patient 
weight gain was  observed.  In this study increased level  of 
thyroid hormone results in increased in blood pressure. This 
may be due to the activation of rennin angiotensin system and 
increased T3 level which increased the synthesis of RBCs by 
activation of erythropoietin
17.  
 
CONCLUSION 
From this study it can be concluded that the cardiac functions 
and  body  homeostasis  were  changed  in  altered  thyroid 
hormone levels and have significant effect on the life style of 
affected person. Although liver enzymes were returned to the 
normal limits but continuous screening is necessary for dose 
adjustment and monitoring of metabolic functions.   
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